Indian Journal of Medical Microbiology IAMM  | About us |  Subscription |  e-Alerts  | Feedback |  Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Ahead of Print | Current Issue | Archives | Search | Instructions  
Users Online: 1104 Official Publication of Indian Association of Medical Microbiologists 
  Search
 
 ~ Next article
 ~ Previous article 
 ~ Table of Contents
  
 ~  Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~  Article in PDF (151 KB)
 ~  Citation Manager
 ~  Access Statistics
 ~  Reader Comments
 ~  Email Alert *
 ~  Add to My List *
* Registration required (free)  

 
 ~  References

 Article Access Statistics
    Viewed15023    
    Printed398    
    Emailed9    
    PDF Downloaded1491    
    Comments [Add]    
    Cited by others 17    

Recommend this journal

 


 
CORRESPONDENCE
Year : 2010  |  Volume : 28  |  Issue : 3  |  Page : 265-266
 

New Delhi metallo-beta-lactamases: A wake-up call for microbiologists


Department of Clinical Microbiology, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom

Date of Submission24-Sep-2009
Date of Acceptance05-Apr-2010
Date of Web Publication17-Jul-2010

Correspondence Address:
BVS Krishna
Department of Clinical Microbiology, Royal Infirmary of Edinburgh, Edinburgh
United Kingdom
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0255-0857.66477

Rights and Permissions



How to cite this article:
Krishna B. New Delhi metallo-beta-lactamases: A wake-up call for microbiologists. Indian J Med Microbiol 2010;28:265-6

How to cite this URL:
Krishna B. New Delhi metallo-beta-lactamases: A wake-up call for microbiologists. Indian J Med Microbiol [serial online] 2010 [cited 2019 Jul 21];28:265-6. Available from: http://www.ijmm.org/text.asp?2010/28/3/265/66477


Dear Editor,

New Delhi metallo-beta-lactamases (NDM) is a nomenclature that Indians cannot be proud of, NDM-1 is the designation for carbapenemases found in enterobacteriaceae isolated from patients in the United Kingdom and elsewhere who have had healthcare contact in India or Pakistan. [1],[2]

Carbapenems (imipenem, ertapenem, meropenem, doripenem) are a class of beta-lactam antibiotics with a broad spectrum of activity against gram-positive, gram-negative, and anaerobic bacteria.

Carbapenemase enzymes belonging to Ambler molecular classes A to D have been detected in various clinical isolates. Of these the class B enzymes are clinically the most significant. They are the metallo-beta-lactamase (MBL) enzymes of the IMP or VIM series that have been reported worldwide. MBL enzymes, whose genes are plasmid and integron located, hydrolyze virtually all beta-lactams except aztreonam. [3] Many of the carbapenemase producers are frequently resistant to fluroquinolones and aminoglycosides.

NDM-1 was first detected in a Klebsiella pneumoniae isolate from a Swedish patient of Indian origin in 2008. The gene coding for this unique enzyme blaNDM-1 was found in one of the three resistance-carrying regions of an integron. NDM-1 shares very little identity with other MBLs. As well as possessing unique residues near the active site, NDM-1 also has an additional insert between positions 162 and 166, which is not present in other MBLs. NDM-1 has a molecular mass of 28 kD and is monomeric. [4]

NDM-1 have been isolated from K pneumoniae,  Escherichia More Details coli, Citrobacter freundii, Enterobacter cloacae, and Morganella morganii. [2] Other classes of carbapenemases have already been found in K pneumoniae, E cloacae, Pseudomonas aeruginosa, and Acinetobacter baumannii. [5]

The first clue to the presence of a carbapenemase comes from the increased minimum inhibitory concentration (MIC) values or frank resistance of the enterobacteriaceae to ertapenem, imipenem, or meropenem. NDM-1 is inhibited by EDTA like other MBL enzymes; this has been demonstrated by the EDTA-disc synergy test. The carbapenemase activity can be screened for by the modified Hodge test. [6] Further characterization and identification of the enzyme can be done only by molecular methods.

Treatment of infections caused by pathogens producing carbapenemases, including NDM-1, poses a serious challenge as these infections are resistant to all commonly used antibiotics. [5] Treatment of patients should be guided by the susceptibilities of the individual pathogens, and clinical laboratories must test for a wide range of antibiotics, including tigecycline, colistin, polymyxin, and aztreonam. The use of antibiotic combinations may have to be considered in desperate cases.

Carbapenems are the only reliably active antibiotics against many multiresistant gram-negative pathogens, particularly those with extended-spectrum beta-lactamases (ESBLs) and AmpC enzymes. [7] The emergence and diversity of carbapenemase-producing strains is therefore a major concern and one that Indian microbiologists cannot afford to ignore.

The virtual nonexistence of antibiotic policies and guidelines in India to help doctors make rational choices with regard to antibiotic treatment is a major driver of the emergence and spread of multidrug resistance in India. This is augmented by the unethical and irresponsible marketing practices of the pharmaceutical industry, and encouraged by the silence and apathy of the regulating authorities. Poor microbiology services in most parts of the country add to the problem.

Microbiologists in India have a very important role in the prevention of spread of these dreaded multiresistant pathogens across the world. They should actively participate in the clinical decision making with regard to the treatment of infections, influence the policies and approach to infections and antimicrobials by the government, develop guidelines for antibiotic therapy in their local hospitals, become infection-control doctors, set up surveillance systems for drug-resistant organisms, and educate healthcare workers and the general public about the dangers of multidrug resistant organisms, including hospital-acquired infections.

 
 ~ References Top

1.Yong D, Giske CG, Toleman M, Walsh TR. A novel subgroup metallo-beta-lactamase (MBL), NDM-1 emerges in Klebsiella pneumoniae (KPN) from India. 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington DC, October 25-28, 2008. 2009;C1-105:87.  Back to cited text no. 1      
2.Health Protection Agency. National Resistance Alert: Carbapenemases in Enterobacteriaceae. Health Protection Report 2009;3:news.   Back to cited text no. 2      
3.Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 2002;8:321-31.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]  
4.Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimirob Agents Chemother 2009;53:5046-54.  Back to cited text no. 4      
5.Walsh TR. Clinically significant carbapenemases: An update. Curr Opin Infect Dis 2008;21:367-71.   Back to cited text no. 5  [PUBMED]  [FULLTEXT]  
6.Lee K, Chong Y, Shin HB, Kim YA, Yong D, Yum JH. Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect 2001;7:88-91.  Back to cited text no. 6  [PUBMED]  [FULLTEXT]  
7.Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: An emerging public-health concern. Lancet Infect Dis 2008;8 :159-66.  Back to cited text no. 7  [PUBMED]  [FULLTEXT]  



This article has been cited by
1 New Delhi Metallo-beta-lactamase around the world: An eReview using Google Maps
M Berrazeg,S Diene,L Medjahed,P Parola,M Drissi,D Raoult,J Rolain
Eurosurveillance. 2014; 19(20): 20809
[Pubmed] | [DOI]
2 Phage-based detection of bacterial pathogens
R. G. van der Merwe,P. D. van Helden,R. M. Warren,S. L. Sampson,N. C. Gey van Pittius
The Analyst. 2014; 139(11): 2617
[Pubmed] | [DOI]
3 Increased WaterborneblaNDM-1Resistance Gene Abundances Associated with Seasonal Human Pilgrimages to the Upper Ganges River
Z. S. Ahammad,T. R. Sreekrishnan,C. L. Hands,C. W. Knapp,D. W. Graham
Environmental Science & Technology. 2014; 48(5): 3014
[Pubmed] | [DOI]
4 Exploring antibiotic resistance based on enzyme hydrolysis by microcalorimetry
Le Zhai,Ke-Wu Yang,Cheng-Cheng Liu,Kang-Zhen Xu,Xia Yang,Hui-Zhou Gao,Ying Shi,Lei Feng,Chao Jia,Li-Sheng Zhou,Jian-Min Xiao
Journal of Thermal Analysis and Calorimetry. 2013; 111(3): 1657
[Pubmed] | [DOI]
5 Exploring antibiotic resistant mechanism by microcalorimetry
Hui-Zhou Gao,Qi Yang,Xiao-Yan Yan,Zhu-Jun Wang,Ji-Li Feng,Xia Yang,Sheng-Li Gao,Lei Feng,Xu Cheng,Chao Jia,Ke-Wu Yang
Journal of Thermal Analysis and Calorimetry. 2012; 107(1): 321
[Pubmed] | [DOI]
6 A study on isolation rate and prevalence of drug resistance among microorganisms isolated from multiorgan donor and donor corneal rim along with a report on existence of bla NDM-1 among Indian population
Murali, S., Jambulingam, M., Tiru, V., Kulanthai, L.T., Rajagopal, R., Padmanaban, P., Madhavan, H.N.
Current Eye Research. 2012; 37(3): 195-203
[Pubmed]
7 Exploring antibiotic resistant mechanism by microcalorimetry : Determination of thermokinetic parameters of metallo-β-lactamase L1 catalyzing penicillin G hydrolysis
Gao, H.-Z., Yang, Q., Yan, X.-Y., Wang, Z.-J., Feng, J.-L., Yang, X., Gao, S.-L., (...), Yang, K.-W.
Journal of Thermal Analysis and Calorimetry. 2012; 107(1): 321-324
[Pubmed]
8 A Study on Isolation Rate and Prevalence of Drug Resistance among Microorganisms Isolated from Multiorgan Donor and Donor Corneal Rim along with a Report on Existence of bla NDM-1 among Indian Population
Sowmiya Murali,Malathi Jambulingam,Vaidehi Tiru,Lily Therese Kulanthai,Rama Rajagopal,Prema Padmanaban,Hajib Naraharirao Madhavan
Current Eye Research. 2012; 37(3): 195
[Pubmed] | [DOI]
9 Thermokinetic characterization of imipenem hydrolysis with metallo-Ŗ-lactamase CcrA from Bacteroides fragilis
Le Zhai,Ke-Wu Yang,Cheng-Cheng Liu,Hui-Zhou Gao,Xia Yang,Ying Shi,Jing Wen
Thermochimica Acta. 2012; 539: 67
[Pubmed] | [DOI]
10 Emergence of New Delhi metallo- β-lactamase, Austria
Zarfel, G., Hoenigl, M., Leitner, E., Salzer, H.J.F., Feierl, G., Masoud, L., Valentin, T., (...), Grisold, A.J.
Emerging Infectious Diseases. 2011; 17(1): 129-130
[Pubmed]
11 NDM-1: A local clone emerges with worldwide aspirations
Marra, A.
Future Microbiology. 2011; 6(2): 137-141
[Pubmed]
12 The emerging NDM carbapenemases
Nordmann, P., Poirel, L., Walsh, T.R., Livermore, D.M.
Trends in Microbiology. 2011; 19(12): 588-595
[Pubmed]
13 Emergence of New Delhi Metallo-Ŗ-Lactamase, Austria
Gernot Zarfel,Martin Hoenigl,Eva Leitner,Helmut J.F. Salzer,Gebhard Feierl,Lilian Masoud,Thomas Valentin,Robert Krause,Andrea J. Grisold
Emerging Infectious Diseases. 2011; 17(1): 129
[Pubmed] | [DOI]
14 Medical tourism: emerging biosecurity and nosocomial issues
C. Michael Hall,Michael James
Tourism Review. 2011; 66(1/2): 118
[Pubmed] | [DOI]
15 The emerging NDM carbapenemases
Patrice Nordmann,Laurent Poirel,Timothy R. Walsh,David M. Livermore
Trends in Microbiology. 2011; 19(12): 588
[Pubmed] | [DOI]
16 NDM-1: a local clone emerges with worldwide aspirations
Andrea Marra
Future Microbiology. 2011; 6(2): 137
[Pubmed] | [DOI]
17 New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: Emergence and response in Europe
Struelens, M.J., Monnet, D.L., Magiorakos, A.P., OśConnor, F.S., Giesecke, J.
Eurosurveillance. 2010; 15(46)
[Pubmed]



 

Top
Print this article  Email this article
Previous article Next article

    

© 2004 - Indian Journal of Medical Microbiology
Published by Wolters Kluwer - Medknow

Online since April 2001, new site since 1st August '04